Posts by: Alice Melão

News

Higher amounts of body fat were linked to an increased risk of chronic kidney disease (CKD) in elderly people, a study published in the Clinical Journal of the American Society ... Read more

May 19, 2017

FDA Approves Design of Phase 2a Trial of Apabetalone for Kidney Disease Patients on Dialysis

News

U.S. regulators have approved the design of a Phase 2a clinical trial of Resverlogix’s apabetalone for treating chronic kidney disease (CKD) patients who are on dialysis. The approval came from the U.S. Food and ... Read more

May 5, 2017

First Creatinine Values at Hospital Admission Can Be Used to Assess Acute Kidney Injury

News

Researchers from Canada showed that using serum creatinine (SCr) values obtained at the time of hospital admission is a reliable method for assessment of acute kidney injury (AKI). In the ... Read more

May 3, 2017May 3, 2017

Xenetic’s Lead Drug Candidate ErepoXen Shows Encouraging Results In CKD Clinical Study

News

Results from a clinical trial of ErepoXen — a therapy developed by Xenetic Biosciences to treat anemia in chronic kidney disease (CKD) patients, show promise, company officials said in a review of their proprietary ... Read more

April 28, 2017April 28, 2017

Chronic Kidney Disease Patients More Likely to Have Gout than Those Without CKD, Study Finds

News

About 10 percent of Americans with chronic kidney disease (CKD) also have gout, concludes a large-scale study based on the National Health and Nutrition Examination Survey (NHANES). The study also ... Read more

April 12, 2017

Largest Medicare Part D Provider Now Covers Auryxia for CKD Patients on Dialysis

News

Keryx Biopharmaceuticals announced that its phosphate binder Auryxia (ferric citrate) has been immediately added to the formularies for the country’s largest Medicare Part D plan provider. This will allow more unrestricted access to ... Read more

February 22, 2017

Study Identifies CKD Patient Risk Groups for Adverse Drug Interactions

News

Patients diagnosed with chronic kidney disease (CKD) who take a lot of prescription medications, have long hospital admissions, have hypertension or who are mature adults (but younger than 60) are ... Read more

January 6, 2017January 6, 2017

Guidance Needed for Managing Pain in CKD Patients on Dialysis, Study Says

News

Severe and even chronic pain is common in chronic kidney disease (CKD) patients undergoing hemodialysis, yet few treatment guidelines exist to help doctors in managing patients’ pain, according to a new study published ... Read more

December 5, 2016December 5, 2016

Specific Inhibitors Can Be Harmful in Kidney Disease Patients, Study Finds

News

A study has found that treating chronic kidney disease (CKD) patients with specific inhibitors such as Arcoxia, Celebrex, Vioxx, and Prexige could induce renal function alterations and electrolyte deregulation. These ... Read more

November 30, 2016November 30, 2016

Common Acid Reflux or Ulcer Medications Can Lead to Kidney Problems, Studies Report

News

Two studies presented at ASN Kidney Week show that common drugs used to treat heartburn, acid reflux, or ulcers, such as proton pump inhibitors (PPI) or histamine receptor-2 blockers (H2), may be ... Read more

November 13, 2016December 9, 2016

Study: Zyloprim Does Not Contribute to Chronic Kidney Disease Risk in Gout Patients

News

A study presented at the 2016 American College of Rheumatology/ARHP Annual Meeting showed that consumption of the commonly used drug allopurinol, trade name Zyloprim, used to lower the levels of urate in ... Read more

October 31, 2016

Intragastric Balloon Treatment for Obesity in CKD Patients Can Lead to Kidney Injuries

News

Weight loss surgery using the intragastric balloon (IGB) method in obese patients with chronic kidney disease (CKD) can lead to a high rate of complications with only a moderate change ... Read more

October 14, 2016November 8, 2016

Promising Study Results for Diabetic Kidney Disease Seen with Mesoblast’s Cell Therapy

News

Mesoblast recently announced positive results from the placebo-controlled Phase 2 trial of its cell therapy MPC-300-IV for diabetic kidney disease patients. All results can be found in the paper “Allogeneic Mesenchymal Precursor ... Read more